Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew B Thompson

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|September 4, 2020
Left anterior descending artery avoidance in patients receiving breast irradiationAleksander Vayntraub, Thomas J Quinn, Andrew B Thompson, et al.
ACS Applied Materials & Interfaces|June 25, 2011
A gold nanoparticle platform for protein-protein interactions and drug discoveryAndrew B Thompson, Amy K Calhoun, Benoit J Smagghe, et al.
Journal of Gastrointestinal Oncology|May 20, 2021
A population-based analysis of chemoradiation versus radiation alone in the definitive treatment of patients with stage I-II squamous cell carcinoma of the anusJacob S Parzen, Aleksander Vayntraub, Bryan Squires, et al.
Pediatric Blood & Cancer|August 30, 2019
Trimodality therapy for atypical teratoid/rhabdoid tumor is associated with improved overall survival: A surveillance, epidemiology, and end results analysisThomas J Quinn, Muayad F Almahariq, Zaid A Siddiqui, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 18, 2020
Post-mastectomy radiotherapy is associated with improved overall survival in T3N0 patients who do not receive chemotherapyMuayad F Almahariq, Thomas J Quinn, Zaid A Siddiqui, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 23, 2021
Higher biologically effective dose is associated with improved survival in patients with squamous cell carcinoma of the lung treated with stereotactic body radiation therapyJacob S Parzen, Muayad F Almahariq, Thomas J Quinn, et al.
Brachytherapy|December 14, 2024
Mature effectiveness and toxicity outcomes associated with three treatment schedules of high-dose-rate brachytherapy monotherapy for favorable-risk prostate cancerKamran Salari, Hong Ye, Alvaro A Martinez, et al.
Brachytherapy|March 21, 2024
21 Gy single fraction prostate HDR brachytherapy: 5-year results of a single institution prospective pilot studyKamran Salari, Allison J Hazy, Hong Ye, et al.
Clinical Lung Cancer|September 3, 2020
The Role of Postoperative Radiation Therapy for pN2 Non-small-cell Lung CancerNikhil P Mankuzhy, Muayad F Almahariq, Zaid A Siddiqui, et al.
Brachytherapy|November 20, 2025
MRI-based predictors of treatment failure in intermediate-risk prostate cancer treated with high-dose-rate brachytherapy as monotherapyJacob F Oyeniyi, Joseph S Lee, Chen Shen, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|September 4, 2020
Left anterior descending artery avoidance in patients receiving breast irradiationAleksander Vayntraub, Thomas J Quinn, Andrew B Thompson, et al.
ACS Applied Materials & Interfaces|June 25, 2011
A gold nanoparticle platform for protein-protein interactions and drug discoveryAndrew B Thompson, Amy K Calhoun, Benoit J Smagghe, et al.
Journal of Gastrointestinal Oncology|May 20, 2021
A population-based analysis of chemoradiation versus radiation alone in the definitive treatment of patients with stage I-II squamous cell carcinoma of the anusJacob S Parzen, Aleksander Vayntraub, Bryan Squires, et al.
Pediatric Blood & Cancer|August 30, 2019
Trimodality therapy for atypical teratoid/rhabdoid tumor is associated with improved overall survival: A surveillance, epidemiology, and end results analysisThomas J Quinn, Muayad F Almahariq, Zaid A Siddiqui, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 18, 2020
Post-mastectomy radiotherapy is associated with improved overall survival in T3N0 patients who do not receive chemotherapyMuayad F Almahariq, Thomas J Quinn, Zaid A Siddiqui, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 23, 2021
Higher biologically effective dose is associated with improved survival in patients with squamous cell carcinoma of the lung treated with stereotactic body radiation therapyJacob S Parzen, Muayad F Almahariq, Thomas J Quinn, et al.
Brachytherapy|December 14, 2024
Mature effectiveness and toxicity outcomes associated with three treatment schedules of high-dose-rate brachytherapy monotherapy for favorable-risk prostate cancerKamran Salari, Hong Ye, Alvaro A Martinez, et al.
Brachytherapy|March 21, 2024
21 Gy single fraction prostate HDR brachytherapy: 5-year results of a single institution prospective pilot studyKamran Salari, Allison J Hazy, Hong Ye, et al.
Clinical Lung Cancer|September 3, 2020
The Role of Postoperative Radiation Therapy for pN2 Non-small-cell Lung CancerNikhil P Mankuzhy, Muayad F Almahariq, Zaid A Siddiqui, et al.
Brachytherapy|November 20, 2025
MRI-based predictors of treatment failure in intermediate-risk prostate cancer treated with high-dose-rate brachytherapy as monotherapyJacob F Oyeniyi, Joseph S Lee, Chen Shen, et al.
Pageof 3